Drug Search Results
More Filters [+]

HY-0902

Alternative Names: HY-0902, HY 0902, HY0902
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Shandong University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for HY-0902

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Gout

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20242128

P1

Unknown

Gout

None

Recent News Events

Date

Type

Title